Hayden's Hope

Tuesday, November 15, 2011

More good news on FOP Research

NIH TRND program announces next round of drug development projects

An inhibitor compound for treatment of fibrodysplasia ossificans progressiva. 
Kenneth D. Bloch, M.D., William T. G. Morton Professor of Anesthesia
Harvard Medical School, Massachusetts General Hospital, Boston.
Fibrodysplasia ossificans progressiva is a rare inherited disorder where muscle and connective tissue such as tendons and ligaments are gradually replaced by bone. The compound under development has shown efficacy in a mouse disease model.

1 comment:

  1. Good news! Yay! PS: Link to HH is official now - in my sidebar. (-: Also talked to Blogher editor today - they now "have everything" so I am hoping the post will go live tomorrow on Blogher. If I see it/hear anything I will let you know.